-
-
30/09/2021 30/09/2021 America/Toronto Life Sciences Antitrust Life Sciences Antitrust
September 30, 2021
Virtual Conference
Please visit https://www.americanconference.com/life-sciences-antitrust/ for more information and updates. Virtual Conference true DD/MM/YYYY 1440 use-title -
-
-
30/09/2021 30/09/2021 America/Toronto Life Sciences Antitrust Life Sciences Antitrust
September 30, 2021
Virtual Conference
Please visit https://www.americanconference.com/life-sciences-antitrust/ for more information and updates. Virtual Conference true DD/MM/YYYY 1440 use-title -
A Deep Dive Into Recent Criminal Generic Price Fixing Cases And How They May Change the Outlook for Competition in the Industry
Renata B. Hesse
Partner, Co-Head of Antitrust Group
Sullivan & Cromwell LLP
(Former Deputy Assistant Attorney General, U.S. DOJ, Antitrust Division, 2012-2017)
Jeffrey (Jeff) D. Martino
Partner
Baker & McKenzie LLP
- Examining the latest series of lawsuits brought by state AG’s offices alleging collusion to fix prices for generic
- Assessing recent actions brought by the DOJ alleging conspiracy to fix prices for generic drugs
- Sandoz, March 2020
- Glenmark Pharmaceuticals, June 2020
- Taro U.S.A., July 2020
- Teva, August 2020
- What are the DOJ and state AGs looking at in these cases, and will these ongoing criminal antitrust investigations cause permanent changes within the industry?